The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 20:466-472, November 2008
doi: 10.1176/appi.neuropsych.20.4.466
© 2008 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Brandt, J.
* Articles by Ross, C. A.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Brandt, J.
* Articles by Ross, C. A.
Related Collections
* Huntington's Disease
* Genetics

Neuropsychological Deficits in Huntington’s Disease Gene Carriers and Correlates of Early "Conversion"

Jason Brandt, Ph.D., Anjeli B. Inscore, Psy.D., Julianna Ward, Ph.D., Barnett Shpritz, O.D., M.A., Adam Rosenblatt, M.D., Russell L. Margolis, M.D. and Christopher A. Ross, M.D., Ph.D.

Received September 26, 2007; revised January 15, 2008; accepted January 31, 2008. The authors are affiliated with the Department of Psychiatry and Behavioral Sciences at The Johns Hopkins University School of Medicine in Baltimore; Drs. Brandt, Margolis, and Ross are also affiliated with the Department of Neurology and Dr. Ross is affiliated with the Department of Neurosciences at The Johns Hopkins University School of Medicine. Address correspondence to Jason Brandt, Ph.D., The Johns Hopkins Hospital, 600 N. Wolfe St., Meyer 218, Baltimore, MD 21287-7218; jbrandt{at}jhmi.edu (e-mail).

The authors examined whether the baseline cognitive functioning of 21 clinically normal huntingtin mutation carriers who developed manifest Huntington’s disease on follow-up differed from that of 49 mutation carriers who remain asymptomatic over the same period in a longitudinal study. One hundred thirty-four gene-negative offspring of Huntington’s disease patients were studied as well. Overall, there were no differences in cognitive test performance among the three groups. However, "converters" who developed signs of Huntington’s disease within 8.6 years demonstrated poorer performance on the Wisconsin Card Sorting Test at baseline. People with the Huntington’s disease mutation who are carefully examined neurologically and found to be asymptomatic have, at most, very minimal problem-solving impairment, and only if they are within a few years of clinical onset.







Get information about faster international access.

Privacy Policy

Copyright © 2008 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org